Risk of fracture at specific sites differed by cause of kidney failure, investigators found.
Strict management of secondary hyperparathyroidism may be necessary to improve prognosis in patients on dialysis who have coronary artery disease requiring percutaneous coronary intervention.
The hospitalization rate and number of hospital days increased significantly in the year after parathyroidectomy vs the year before, whereas dialysis visits and office visits decreased significantly.
Serum levels of phosphate and parathyroid hormone are lower early in the day and higher late in the day, recently reported data suggest.
In a retrospective study, investigators found that radiofrequency ablation and parathyroidectomy for secondary hyperparathyroidism in patients on dialysis achieved intact parathyroid hormone levels in the target range in similar proportions of patients.
A retrospective case-control study indicates that parathyroidectomy improves patient-level outcomes.
Coronary calcification developed with poorly controlled tertiary hyperparathyroidism and elevated iFGF23 levels after transplantation, the investigators reported.
Vitamin D deficiency and secondary hyperparathyroidism are associated with more rapid bone decline in older men.
Among adults not selected for vitamin D deficiency, low bone mass, or osteoporosis, no effect seen on total, nonvertebral, or hip fracture risk
Treatment of elevated parathyroid hormone levels prior to kidney transplantation should be considered, according to investigators.